OncoMatch/Clinical Trials/NCT07120295
Study of Large Channel Digital Pancreaticobiliary Scope (DPS) With Compatible Accessories
Is NCT07120295 recruiting? Yes, currently enrolling (May 2026). This Phase 4 trial studies Dragonfly™ Digital Pancreaticobiliary System for bile duct adenocarcinoma.
Treatment: Dragonfly™ Digital Pancreaticobiliary System — This study plans to enroll up to 75 research subject who have a biliary disorder such as bile duct stones or intermediate biliary strictures. The purpose of this research is to assess whether the Dragonfly™ Pancreaticobiliary Scope functioned as intended in combination with the commercially available accessories during your scheduled endoscopy procedure. This includes achieving stone fragmentation of difficult biliary stone(s) while obtaining adequate tissue specimens for analysis. There will also be a Product performance evaluation as rated by the endoscopist operating the DPS System and evaluation of ergonomics and usability.
Check if I qualifyExtracted eligibility criteria
Lab requirements
Blood counts
coagulopathy (inr > 1.8) or thrombocytopenia (platelets < 50,000) that is not correctable and felt to be a contraindication to proceeding with biopsy or lithotripsy per the treating endoscopist
Structured fields extracted by AI. May contain errors — verify against the official protocol.
US trial sites
- Universtiy of Colorado Hospital · Aurora, Colorado
Showing up to 5 US sites. See all sites on ClinicalTrials.gov →
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify